Contact
Please use this form to send email to PR contact of this press release:
scPharmaceuticals Inc. Announces Results of Type A End-of-Review Meeting with FDA Regarding FUROSCIX® NDA
TO:
Please use this form to send email to PR contact of this press release:
scPharmaceuticals Inc. Announces Results of Type A End-of-Review Meeting with FDA Regarding FUROSCIX® NDA
TO: